The effect of BCG vaccination and risk factors for latent tuberculosis infection among college freshmen in China

The effect of BCG vaccination and risk factors for latent tuberculosis infection among college freshmen in China

Objectives: In this study, we aimed to verify whether Bacillus Calmette–Guérin (BCG) can protect first-year college students against Mycobacterium tuberculosis (MTB) infection by the recombinant fusion protein ESAT6-CFP10 skin test (ECST) or the tuberculin skin test (TST). Methods: We conducted a cr...

Full description

Bibliographic Details
Main Authors:	Wei Huang, Zhixiong Fang, Si Luo, Sha Lin, Lei Xu, Bo Yan, Yang yang, Xuhui Liu, Lu Xia, Xiaoyong Fan, Shuihua Lu
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	International Journal of Infectious Diseases
Subjects:	BCG vaccine Mycobacterium tuberculosis infection Vaccine effectiveness ECST TST
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971222003459

Similar Items

The role of BCG in prevention of tuberculosis and the strategies to improve its immunogenicity
by: Jolanta Mazurek
Published: (2018-03-01)

Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study
by: Birger Trollfors, MD, et al.
Published: (2021-08-01)

Fighting Tuberculosis: In Search of a BCG Replacement
by: Nonna I. Nadolinskaia, et al.
Published: (2022-12-01)

Advances in the characterization of a proteol iposome derived from Mycobacterium bovis BCG as vaccine candidate against tuberculosis
by: Nadine Alvarez-Cabrera, et al.
Published: (2014-12-01)

Nonclinical Development of BCG Replacement Vaccine Candidates
by: Bernd Eisele, et al.
Published: (2013-04-01)

Difference in Severity of Tuberculosis in Children with or without a BCG Scar
by: Gunadi Santosa, et al.
Published: (2019-04-01)

Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
by: Farzad Khademi, et al.
Published: (2018-01-01)

Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland
by: Eileen Sweeney, et al.
Published: (2019-05-01)

Molecular analysis of Mycobacterium isolates from patients with BCG-induced lymphadenitis
by: Farahnoosh Doustdar, et al.
Published: (2015-01-01)

Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis
by: C. Kanipe, et al.
Published: (2022-11-01)

BCG vaccination strategies against tuberculosis: updates and perspectives
by: Mengjin Qu, et al.
Published: (2021-12-01)

Contemporary aspects of tuberculosis in children without BCG vaccination
by: M. N. Kondаkovа, et al.
Published: (2021-04-01)

BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells
by: Harindra D. Sathkumara, et al.
Published: (2019-03-01)

Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine
by: Lwandile Bukula, et al.
Published: (2025-03-01)

Vaccine research and development: tuberculosis as a global health threat
by: Mohammed Maikudi Usman, et al.
Published: (2017-08-01)

Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice
by: Danang Fang, et al.
Published: (2024-12-01)

COMPARATIVE ANALYSIS OF THE FREQUENCY AND STRUCTURE OF COMPLICATIONS OF THE BCG AND BCG-M TUBERCULOSIS VACCINE
by: Pozdnyakova A. S.
Published: (2021-03-01)

Effectiveness Of BCG Vaccination in Prevention of Childhood Tuberculosis: A Prospective Study from Kishanganj, Bihar
by: Kashif Shahnawaz, et al.
Published: (2013-09-01)

Identification of DNA methylation patterns predisposing for an efficient response to BCG vaccination in healthy BCG-naïve subjects
by: Jyotirmoy Das, et al.
Published: (2019-06-01)

An Overview of the Development of New Vaccines for Tuberculosis
by: E. Whitlow, et al.
Published: (2020-10-01)

A modified BCG with depletion of enzymes associated with peptidoglycan amidation induces enhanced protection against tuberculosis in mice
by: Moagi Tube Shaku, et al.
Published: (2024-04-01)

Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda
by: Lawrence Lubyayi, et al.
Published: (2020-05-01)

Frequency of absent BCG Scar in Babies Vaccinated with BCG
by: Aqeela Sami, et al.
Published: (2023-07-01)

Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG
by: Gil R. Diogo, et al.
Published: (2019-06-01)

The Interferon-Gamma Release Assay versus the Tuberculin Skin Test in the Diagnosis of <i>Mycobacterium tuberculosis</i> Infection in BCG-Vaccinated Children and Adolescents Exposed or Not Exposed to Contagious TB
by: Magdalena Druszczynska, et al.
Published: (2023-02-01)

Protective Efficacy of BCG Vaccination in Calves Vaccinated at Different Ages
by: Jayne C. Hope, et al.
Published: (2023-05-01)

A new DNA vaccine expressing HspX-PPE44-EsxV fusion antigens of Mycobacterium tuberculosis induced strong immune responses
by: Bagher Moradi, et al.
Published: (2020-07-01)

BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion of <i>Mycobacterium tuberculosis</i>-Specific IFN-γ Release
by: Dorcas O. Owusu, et al.
Published: (2023-04-01)

Vacina BCG contra tuberculose: efeito protetor e políticas de vacinação BCG vaccine against tuberculosis: its protective effect and vaccination policies
by: Susan M Pereira, et al.
Published: (2007-09-01)

Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile in vitro when compared with Russia, Pasteur, and Danish strains
by: Andreon Santos Machado da Silva, et al.
Published: (2022-01-01)

Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
by: Mi-Hyun Lee, et al.
Published: (2023-06-01)

A review of the BCG vaccine and other approaches toward tuberculosis eradication
by: Thomas Cho, et al.
Published: (2021-08-01)

The current status, challenges, and future developments of new tuberculosis vaccines
by: Wenping Gong, et al.
Published: (2018-07-01)

BCG-osis after BCG vaccination in immunocompromised children: Case series and review
by: Soheila Shahmohammadi, et al.
Published: (2014-02-01)

A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice
by: V.L. Petricevich, et al.
Published: (2001-01-01)

Bacille Calmette–Guérin (BCG) Vaccine Induced Tuberculous Lymphadenitis: A Case Report
by: Kalyan Sapkota
Published: (2020-12-01)

A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017–2022
by: Masashi Nishimura, et al.
Published: (2023-01-01)

PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION
by: V. V. Yeremeev, et al.
Published: (2019-07-01)

PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION
by: Vladimir Yeremeev, et al.
Published: (2019-03-01)

Contacts of retreatment tuberculosis cases with a prior poor treatment outcome are at increased risk of latent tuberculosis infection
by: Davit Baliashvili, et al.
Published: (2016-02-01)